Astrocyte Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2026
Total raised
- $23M
Investors
- 14
About Astrocyte Pharmaceuticals
Founded in 2014 and based in Connecticut, US, Astrocyte Pharmaceuticals Inc. operates as a biotechnology company that focuses on developing program for treating brain injuries and disorders. William S. Korinek (CEO) and James D. Lechleiter are the co-founders of the company. In September 2026, Astrocyte Pharmaceuticals Inc. The company is developing treatments for medical needs in acute ischemic stroke, traumatic brain injury (TBI), concussion, and related conditions through research and development. The firm's lead candidate, AST-004, is a novel small molecule currently undergoing human Phase I clinical safety trials. This candidate is being tested in an intravenous injection formulation designed for use by emergency medical professionals in the treatment of acute ischemic stroke. In addition, this oral formulation is being explored for chronic administration to address neurodegenerative diseases such as Alzheimer's. Astrocyte Pharmaceuticals' pipeline includes several candidates at various stages of development, including AST-004 (Acute Ischemic Stroke), AST-004 (Severe-Moderate TBI), AST-004 (Concussion/Mild TBI), AST-004 (Alzheimer’s Disease), AST-008 (Pain/Migraine), and undisclosed candidates.
Who invested in Astrocyte Pharmaceuticals
14 investors across 3 rounds
See all investors in Astrocyte Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Astrocyte Pharmaceuticals
Who invested in Astrocyte Pharmaceuticals?
Astrocyte Pharmaceuticals has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Astrocyte Pharmaceuticals raised?
Astrocyte Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Astrocyte Pharmaceuticals last raise money?
Astrocyte Pharmaceuticals's most recent round on record is a Series B, in Sep 2026.
What does Astrocyte Pharmaceuticals do?
Founded in 2014 and based in Connecticut, US, Astrocyte Pharmaceuticals Inc.
Where is Astrocyte Pharmaceuticals headquartered?
Astrocyte Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Astrocyte Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Astrocyte Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Astrocyte Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.